PIM
Partner Investment Management Portfolio holdings
AUM
$13.9M
1-Year Return
49.21%
This Quarter Return
+8.82%
1 Year Return
+49.21%
3 Year Return
+140.34%
5 Year Return
+258.27%
10 Year Return
–
AUM
$84M
AUM Growth
+$15.4M
(+22%)
Cap. Flow
+$6.35M
Cap. Flow
% of AUM
7.56%
Top 10 Holdings %
Top 10 Hldgs %
36.03%
Holding
101
New
14
Increased
34
Reduced
19
Closed
19
Top Buys
| 1 |
SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
|
$6.7M |
| 2 |
AGN.PRA
Allergan plc.
AGN.PRA
|
$1.76M |
| 3 |
Centene
CNC
|
$1.61M |
| 4 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$1.58M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
$1.21M |
Top Sells
| 1 |
KITE
Kite Pharma, Inc.
KITE
|
$5.1M |
| 2 |
Universal Health Services
UHS
|
$1.85M |
| 3 |
Pacira BioSciences
PCRX
|
$1.72M |
| 4 |
McKesson
MCK
|
$1.63M |
| 5 |
Alibaba
BABA
|
$1.22M |
Sector Composition
| 1 | Healthcare | 43.13% |
| 2 | Technology | 17.68% |
| 3 | Communication Services | 7.49% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Financials | 4.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Visa
V
$668B
| $474K | 0.45% |
4,502
-7,912
| -64% | -$833K |
|
52
Esperion Therapeutics
ESPR
$542M
| $457K | 0.43% |
9,119
+5,096
| +127% | +$255K |
|
53
Merit Medical Systems
MMSI
$5.5B
| $452K | 0.43% |
10,680
+4,572
| +75% | +$193K |
|
|
ELGX
54
DELISTED
Endologix Inc
ELGX
| $441K | 0.42% |
9,882
-92
| -0.9% | -$4.11K |
|
|
HRC
55
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $396K | 0.38% |
5,356
+2,483
| +86% | +$184K |
|
56
Kura Oncology
KURA
$729M
| $384K | 0.36% |
25,717
+2,921
| +13% | +$43.6K |
|
57
Inogen
INGN
$224M
| $348K | 0.33% |
+3,659
| New | +$348K |
|
|
CLVS
58
DELISTED
Clovis Oncology, Inc.
CLVS
| $334K | 0.32% |
4,053
-2,551
| -39% | -$210K |
|
|
XENT
59
DELISTED
Intersect ENT, Inc
XENT
| $309K | 0.29% |
9,913
+2,902
| +41% | +$90.5K |
|
60
Vulcan Materials
VMC
$38.7B
| $298K | 0.28% |
2,488
| – | – |
|
61
LendingClub
LC
$1.9B
| $233K | 0.22% |
+7,655
| New | +$233K |
|
|
JNCE
62
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $222K | 0.21% |
14,265
+7,170
| +101% | +$112K |
|
|
CSII
63
DELISTED
Cardiovascular Systems, Inc.
CSII
| $186K | 0.18% |
6,602
+582
| +10% | +$16.4K |
|
64
Accuray
ARAY
$170M
| $185K | 0.18% |
46,229
-5,699
| -11% | -$22.8K |
|
|
CUTR
65
DELISTED
Cutera, Inc.
CUTR
| $180K | 0.17% |
+4,349
| New | +$180K |
|
|
PRAH
66
DELISTED
PRA Health Sciences, Inc.
PRAH
| $142K | 0.13% |
+1,865
| New | +$142K |
|
|
NITE
67
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| $103K | 0.1% |
+5,350
| New | +$103K |
|
68
Voyager Therapeutics
VYGR
$236M
| $100K | 0.09% |
4,844
-11,573
| -70% | -$239K |
|
|
KITE
69
DELISTED
Kite Pharma, Inc.
KITE
| $14K | 0.01% |
79
-28,758
| -100% | -$5.1M |
|
70
Regenxbio
RGNX
$502M
| – | – |
-4,824
| Closed | -$95K |
|
71
Apple
AAPL
$3.56T
| – | – |
-11,820
| Closed | -$426K |
|
72
American Tower
AMT
$92.9B
| – | – |
-5,084
| Closed | -$673K |
|
73
Biogen
BIIB
$20.9B
| – | – |
-248
| Closed | -$67K |
|
74
Booking.com
BKNG
$179B
| – | – |
-176
| Closed | -$329K |
|
75
BioMarin Pharmaceuticals
BMRN
$11.1B
| – | – |
-3,973
| Closed | -$361K |
|